These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 24972190

  • 1. Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer.
    Laskov I, Drudi L, Beauchamp MC, Yasmeen A, Ferenczy A, Pollak M, Gotlieb WH.
    Gynecol Oncol; 2014 Sep; 134(3):607-14. PubMed ID: 24972190
    [Abstract] [Full Text] [Related]

  • 2. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
    Mitsuhashi A, Kiyokawa T, Sato Y, Shozu M.
    Cancer; 2014 Oct 01; 120(19):2986-95. PubMed ID: 24917306
    [Abstract] [Full Text] [Related]

  • 3. Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.
    Niraula S, Dowling RJ, Ennis M, Chang MC, Done SJ, Hood N, Escallon J, Leong WL, McCready DR, Reedijk M, Stambolic V, Goodwin PJ.
    Breast Cancer Res Treat; 2012 Oct 01; 135(3):821-30. PubMed ID: 22933030
    [Abstract] [Full Text] [Related]

  • 4. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.
    Schuler KM, Rambally BS, DiFurio MJ, Sampey BP, Gehrig PA, Makowski L, Bae-Jump VL.
    Cancer Med; 2015 Feb 01; 4(2):161-73. PubMed ID: 25417601
    [Abstract] [Full Text] [Related]

  • 5. Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.
    Soliman PT, Zhang Q, Broaddus RR, Westin SN, Iglesias D, Munsell MF, Schmandt R, Yates M, Ramondetta L, Lu KH.
    Gynecol Oncol; 2016 Dec 01; 143(3):466-471. PubMed ID: 27745917
    [Abstract] [Full Text] [Related]

  • 6. Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.
    Bonanni B, Puntoni M, Cazzaniga M, Pruneri G, Serrano D, Guerrieri-Gonzaga A, Gennari A, Trabacca MS, Galimberti V, Veronesi P, Johansson H, Aristarco V, Bassi F, Luini A, Lazzeroni M, Varricchio C, Viale G, Bruzzi P, Decensi A.
    J Clin Oncol; 2012 Jul 20; 30(21):2593-600. PubMed ID: 22564993
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
    Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH.
    Cancer Epidemiol Biomarkers Prev; 2004 May 20; 13(5):748-52. PubMed ID: 15159305
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of Metformin For Decreasing Proliferative Marker in Women with Endometrial Cancer: A Randomized Double-blind Placebo-Controlled Trial.
    Petchsila K, Prueksaritanond N, Insin P, Yanaranop M, Chotikawichean N.
    Asian Pac J Cancer Prev; 2020 Mar 01; 21(3):733-741. PubMed ID: 32212801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial.
    Kitson SJ, Maskell Z, Sivalingam VN, Allen JL, Ali S, Burns S, Gilmour K, Latheef R, Slade RJ, Pemberton PW, Shaw J, Ryder WD, Kitchener HC, Crosbie EJ.
    Clin Cancer Res; 2019 Apr 15; 25(8):2424-2432. PubMed ID: 30563932
    [Abstract] [Full Text] [Related]

  • 14. Measuring the biological effect of presurgical metformin treatment in endometrial cancer.
    Sivalingam VN, Kitson S, McVey R, Roberts C, Pemberton P, Gilmour K, Ali S, Renehan AG, Kitchener HC, Crosbie EJ.
    Br J Cancer; 2016 Feb 02; 114(3):281-9. PubMed ID: 26794276
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA.
    Cancer Epidemiol Biomarkers Prev; 2004 Apr 02; 13(4):607-12. PubMed ID: 15066926
    [Abstract] [Full Text] [Related]

  • 17. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
    Lange C, Machado Weber A, Schmidt R, Schroeder C, Strowitzki T, Germeyer A.
    PLoS One; 2021 Apr 02; 16(3):e0248103. PubMed ID: 33690729
    [Abstract] [Full Text] [Related]

  • 18. Metformin is associated with improved survival in endometrial cancer.
    Ko EM, Walter P, Jackson A, Clark L, Franasiak J, Bolac C, Havrilesky LJ, Secord AA, Moore DT, Gehrig PA, Bae-Jump V.
    Gynecol Oncol; 2014 Feb 02; 132(2):438-42. PubMed ID: 24269517
    [Abstract] [Full Text] [Related]

  • 19. Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.
    Campagnoli C, Pasanisi P, Abbà C, Ambroggio S, Biglia N, Brucato T, Colombero R, Danese S, Donadio M, Venturelli E, Zito G, Berrino F.
    Clin Breast Cancer; 2012 Jun 02; 12(3):175-82. PubMed ID: 22607767
    [Abstract] [Full Text] [Related]

  • 20. A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer.
    Joshua AM, Zannella VE, Downes MR, Bowes B, Hersey K, Koritzinsky M, Schwab M, Hofmann U, Evans A, van der Kwast T, Trachtenberg J, Finelli A, Fleshner N, Sweet J, Pollak M.
    Prostate Cancer Prostatic Dis; 2014 Sep 02; 17(3):252-8. PubMed ID: 24861559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.